Home » Topics » Regulatory » Patents

Patents
RSS

DuPont discloses heteroaromatic factor Xa inhibitors

Oct. 22, 1998

NOS inhibitors developed at Chugai reportedly useful for cerebrovascular disorders

Oct. 22, 1998

Antiallergic/antiinflammatory compounds in development at Nikken Chemicals

Oct. 21, 1998

Potent CRF1 receptor antagonists and their use described by Yoshitomi

Oct. 21, 1998

Propionic acid derivatives from Nippon Chemiphar useful for diabetes and related disorders

Oct. 21, 1998

Cephems from Zenyaku Kogyo with improved activity compared to flomoxef, vancomycin

Oct. 21, 1998

Daiichi's new squalene synthase inhibitors

Oct. 21, 1998

Taisho describes antiischemic 2-phenoxyaniline derivatives

Oct. 20, 1998

Dopamine reuptake inhibitors in development at Pola for Parkinson's disease

Oct. 20, 1998

Isoflavone derivatives for osteoporosis with advantages over previously reported compounds

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...